Get Your Obesity Clinical Trial on the Road to Success

According to the Centers for Disease Control and Prevention (CDC), obesity affects more than 93 million adults in the United States – nearly 40% of the adult population. It also affects between 18% and 20% of those between 6 and 19 years old. And obesity is not simply a matter of people being overweight; the epidemic is putting large numbers of people at increased risk for type 2 diabetes, high blood pressure, metabolic syndrome, osteoarthritis, heart disease, stroke, sleep apnea, and many other conditions.

Clearly, reducing the increasing BMI numbers associated with the obesity epidemic is a critical public health goal, but what’s the best way to do that? Worldwide Clinical Trials can help you formulate an answer to that question. With more than 30 years of experience supporting research into new drug therapies, Worldwide is an internationally acclaimed CRO in the area of clinical trial management. We offer full-service Phase IPhase IV and real-world evidence clinical research services for studies focused on medications and techniques to reduce obesity in a safe, meaningful, and long-lasting way.

Our teams of dedicated professionals can provide insightful feedback on development plans, detailed and expert feasibility analyses, and the resources and management skills to deliver a project on time and within budget.